Acute respiratory distress syndrome following alemtuzumab therapy for relapsing multiple sclerosis.
Sign Up to like & getrecommendations! Published in 2017 at "Multiple sclerosis and related disorders"
DOI: 10.1016/j.msard.2017.03.001
Abstract: We present the case of a 54 year old woman with known relapsing-remitting multiple sclerosis who presented with acute respiratory deterioration five weeks after a first course of alemtuzumab. Imaging showed bilateral ground glass changes… read more here.
Keywords: following alemtuzumab; acute respiratory; multiple sclerosis; alemtuzumab therapy ... See more keywords
Autoimmune storm following alemtuzumab
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Case Reports"
DOI: 10.1136/bcr-2021-248037
Abstract: Alemtuzumab has been associated with the emergence of secondary autoimmune diseases. We report a case of a patient with relapsing–remitting multiple sclerosis who developed a refractory immune thrombocytopaenia associated with vasculitis, myelofibrosis and later Guillain-Barré… read more here.
Keywords: following alemtuzumab; storm following; autoimmune storm;
Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Neuroinflammation"
DOI: 10.1186/s12974-020-01847-9
Abstract: Objective To characterize long-term repopulation of peripheral immune cells following alemtuzumab-induced lymphopenia in relapsing-remitting MS (RRMS), with a focus on regulatory cell types, and to explore associations with clinical outcome measures. Methods The project was… read more here.
Keywords: relapsing remitting; cells following; treatment; following alemtuzumab ... See more keywords